Debt-to-equity of Shuttle Pharmaceuticals Holdings, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Shuttle Pharmaceuticals Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Shuttle Pharmaceuticals Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 88%, a 30% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Shuttle Pharmaceuticals Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 88% -38% -30% 30 Sep 2025
Q2 2025 123% +65% +112% 30 Jun 2025
Q1 2025 225% +186% +476% 31 Mar 2025
Q4 2024 263% +225% +581% 31 Dec 2024
Q3 2024 125% +95% +315% 30 Sep 2024
Q2 2024 58% +33% +135% 30 Jun 2024
Q1 2024 39% 31 Mar 2024
Q4 2023 39% 31 Dec 2023
Q3 2023 30% 30 Sep 2023
Q2 2023 25% 30 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.